- Report
- October 2024
- 193 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- June 2023
- 183 Pages
Global
From €2606EUR$2,750USD£2,178GBP
€5213EUR$5,500USD£4,355GBP
- Report
- January 2024
- 94 Pages
United States
From €5640EUR$5,950USD£4,711GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Gadobutrol is a type of contrast media used in medical imaging. It is a gadolinium-based contrast agent, which is injected into the body to improve the visibility of organs and tissues during magnetic resonance imaging (MRI) scans. Gadobutrol is used to enhance the contrast between normal and abnormal tissues, allowing for more accurate diagnosis. It is also used to detect and monitor certain diseases, such as cancer, and to evaluate the effectiveness of treatments.
Gadobutrol is available in a variety of formulations, including liquid and powder forms. It is typically administered intravenously, but can also be administered orally or rectally. The safety and efficacy of gadobutrol have been established in clinical trials, and it is approved for use in many countries.
Gadobutrol is manufactured by several companies, including Bayer, Bracco, Guerbet, and Mallinckrodt. It is available in a variety of formulations, including liquid and powder forms. Show Less Read more